How cholesterol interacts with membrane proteins: an exploration of cholesterol-binding sites including CRAC, CARC, and tilted domains

Abstract

The plasma membrane of eukaryotic cells contains several types of lipids displaying high biochemical variability in both their apolar moiety (e.g., the acyl chain of glycerolipids) and their polar head (e.g., the sugar structure of glycosphingolipids). Among these lipids, cholesterol is unique because its biochemical variability is almost exclusively restricted to the oxidation of its polar -OH group. Although generally considered the most rigid membrane lipid, cholesterol can adopt a broad range of conformations due to the flexibility of its isooctyl chain linked to the polycyclic sterane backbone. Moreover, cholesterol is an asymmetric molecule displaying a planar α face and a rough β face. Overall, these structural features open up a number of possible interactions between cholesterol and membrane lipids and proteins, consistent with the prominent regulatory functions that this unique lipid exerts on membrane components. The aim of this review is to describe how cholesterol interacts with membrane lipids and proteins at the molecular/atomic scale, with special emphasis on transmembrane domains of proteins containing either the consensus cholesterol-binding motifs CRAC and CARC or a tilted peptide. Despite their broad structural diversity, all these domains bind cholesterol through common molecular mechanisms, leading to the identification of a subset of amino acid residues that are overrepresented in both linear and three-dimensional membrane cholesterol-binding sites.

Full text

Its licence does not allow us to show the full text. Read it at PubMed Central:

References 50

1. 1.

   Anderson R. G. Jacobson K. (2002 ). A role for lipid shells in targeting proteins to caveolae, rafts, and other lipid domains. Science 296, 1821–1825

   Not in our library10.1126/science.1068886

2. 2.

   Baier C. J. Fantini J. Barrantes F. J. (2011 ). Disclosure of cholesterol recognition motifs in transmembrane domains of the human nicoticin acetylcholine receptor. Sci. Reports 1:69

   Not in our library10.1038/srep00069

3. 3.

   Ballesteros J. Weinstein H. (1995 ). Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors. Methods Neurosci. 25, 366–428

   Not in our library

4. 4.

   Barrantes F. J. Borroni V. Vallés S. (2010 ). Neuronal nicotinic acetylcholine receptor-cholesterol crosstalk in Alzheimer's disease. FEBS Lett. 584, 1856–1863

   Not in our library10.1016/j.febslet.2009.11.036

5. 5.

   Barrett P. J. Song Y. Van Horn W. D. Hustedt E. J. Schafer J. M. Hadziselimovic A. (2012 ). The amyloid precursor protein has a flexible transmembrane domain and binds cholesterol. Science 336, 1168–1171

   Not in our library10.1126/science.1219988

6. 6.

   Charloteaux B. Lorin A. Brasseur R. Lins L. (2009 ). The “Tilted Peptide Theory” links membrane insertion properties and fusogenicity of viral fusion peptides. Protein Pept. Lett. 16, 718–725

   Not in our library10.2174/092986609788681724

7. 7.

   Charloteaux B. Lorin A. Crowet J. M. Stroobant V. Lins L. Thomas A. (2006 ). The N-terminal 12 residue long peptide of HIV gp41 is the minimal peptide sufficient to induce significant T-cell-like membrane destabilization in vitro. J. Mol. Biol. 359, 597–609

   Not in our library10.1016/j.jmb.2006.04.018

8. 8.

   Crowet J. M. Lins L. Dupiereux I. Elmoualija B. Lorin A. Charloteaux B. (2007 ). Tilted properties of the 67-78 fragment of alpha-synuclein are responsible for membrane destabilization and neurotoxicity. Proteins 68, 936–947

   Not in our library10.1002/prot.21483

9. 9.

   Di Scala C. Yahi N. Lelièvre C. Garmy N. Chahinian H. Fantini J. (2013 ). Biochemical identification of a linear cholesterol-binding domain within Alzheimer's β amyloid peptide. ACS Chem. Neurosci, (in press).

   Not in our library10.1021/cn300203a

10. 10.

    Epand R. F. Thomas A. Brasseur R. Vishwanathan S. A. Hunter E. Epand R. M. (2006 ). Juxtamembrane protein segments that contribute to recruitment of cholesterol into domains. Biochemistry 45, 6105–6114

    Not in our library10.1021/bi060245+

11. 11.

    Epand R. M. (2006 ). Cholesterol and the interaction of proteins with membrane domains. Prog. Lipid Res. 45, 279–294

    Not in our library10.1016/j.plipres.2006.02.001

12. 12.

    Epand R. M. Thomas A. Brasseur R. Epand R. F. (2010 ). Cholesterol interaction with proteins that partition into membrane domains: an overview. Subcell. Biochem. 51, 253–278

    Not in our library10.1007/978-90-481-8622-8_9

13. 13.

    Fantini J. Barrantes F. J. (2009 ). Sphingolipid/cholesterol regulation of neurotransmitter receptor conformation and function. Biochim. Biophys. Acta 1788, 2345–2361

    Not in our library10.1016/j.bbamem.2009.08.016

14. 14.

    Fantini J. Carlus D. Yahi N. (2011 ). The fusogenic tilted peptide (67-78) of α-synuclein is a cholesterol binding domain. Biochim. Biophys. Acta 1808, 2343–2351

    Not in our library10.1016/j.bbamem.2011.06.017

15. 15.

    Fantini J. Garmy N. Mahfoud R. Yahi N. (2002 ). Lipid rafts: structure, function and role in HIV, Alzheimer's and prion diseases. Expert Rev. Mol. Med. 4, 1–22

    Not in our library10.1017/s1462399402005392

16. 16.

    Fantini J. Yahi N. (2010 ). Molecular insights into amyloid regulation by membrane cholesterol and sphingolipids: common mechanisms in neurodegenerative diseases. Expert Rev. Mol. Med. 12:e27

    Not in our library10.1017/s1462399410001602

17. 17.

    Fantini J. Yahi N. (2011 ). Molecular basis for the glycosphingolipid-binding specificity of α-synuclein: key role of tyrosine 39 in membrane insertion. J. Mol. Biol. 408, 654–669

    Not in our library10.1016/j.jmb.2011.03.009

18. 18.

    Garmy N. Taïeb N. Yahi N. Fantini J. (2005 ). Interaction of cholesterol with sphingosine: physicochemical characterization and impact on intestinal absorption. J. Lipid Res. 46, 36–45

    Not in our library10.1194/jlr.m400199-jlr200

19. 19.

    Gimpl G. (2010 ). Cholesterol-protein interaction: methods and cholesterol reporter molecules. Subcell. Biochem. 5, 1–45

    Not in our library10.1007/978-90-481-8622-8_1

20. 20.

    Hanson M. A. Cherezov V. Griffith M. T. Roth C. B. Jaakola V. P. Chien E. Y. (2008 ). A specific cholesterol binding site is established by the 2.8 Å structure of the human beta2-adrenergic receptor. Structure 16, 897–905

    Not in our library10.1016/j.str.2008.05.001

21. 21.

    Harris J. R. Palmer M. (2010 ). Cholesterol specificity of some heptameric beta-barrel pore-forming bacterial toxins: structural and functional aspects. Subcell. Biochem. 51, 579–596

    Not in our library10.1007/978-90-481-8622-8_21

22. 22.

    Harris J. S. Epps D. E. Davio S. R. Kézdy F. J. (1995 ). Evidence for transbilayer, tail-to-tail cholesterol dimers in dipalmitoylglycerophosphocholine liposomes. Biochemistry 34, 3851–3857

    Not in our library10.1021/bi00011a043

23. 23.

    Ikonen E. (2008 ). Cellular cholesterol trafficking and compartmentalization. Nat. Rev. Mol. Cell Biol. 9, 125–138

    Not in our library10.1038/nrm2336

24. 24.

    Jafurulla M. Tiwari S. Chattopadhyay A. (2011 ). Identification of cholesterol recognition amino acid consensus (CRAC) motif in G-protein coupled receptors. Biochem. Biophys. Res. Commun. 404, 569–573

    Not in our library10.1016/j.bbrc.2010.12.031

25. 25.

    Jamin N. Neumann J. M. Ostuni M. A. Vu T. K. Yao Z. X. Murail S. (2005 ). Characterization of the cholesterol recognition amino acid consensus sequence of the peripheral-type benzodiazepine receptor. Mol. Endocrinol. 19, 588–594

    Not in our library10.1210/me.2004-0308

26. 26.

    Lee A. G. (2003 ). Lipid-protein interactions in biological membranes: a structural perspective. Biochim. Biophys. Acta 1612, 1–40

    Not in our library10.1016/s0005-2736(03)00056-7

27. 27.

    Lee A. G. (2011 ). Lipid-protein interactions. Biochem. Soc. Trans. 39, 761–766

    Not in our library10.1042/bst0390761

28. 28.

    Li H. Papadopoulos V. (1998 ). Peripheral-type benzodiazepine receptor function in cholesterol transport. Identification of a putative cholesterol recognition/interaction amino acid sequence and consensus pattern. Endocrinology 139, 4991–4997

    Not in our library10.1210/en.139.12.4991

29. 29.

    Lins L. Decaffmeyer M. Thomas A. Brasseur R. (2008 ). Relationships between the orientation and the structural properties of peptides and their membrane interactions. Biochim. Biophys. Acta 1778, 1537–1544

    Not in our library10.1016/j.bbamem.2008.04.006

30. 30.

    Marsh D. (2008 ). Protein modulation of lipids, and vice-versa, in membranes. Biochim. Biophys. Acta 1778, 1545–1575

    Not in our library10.1016/j.bbamem.2008.01.015

31. 31.

    Marsh D. (2010 ). Electron spin resonance in membrane research: protein–lipid interactions from challenging beginnings to state of the art. Eur. Biophys. J. 39, 513–525

    Not in our library10.1007/s00249-009-0512-3

32. 32.

    Marsh D. Pali T. (2012 ). Orientation and conformation of lipids in crystals of transmembrane proteins. Eur. Biophys. J. [Epub ahead of print].

    Not in our library10.1007/s00249-012-0816-6

33. 33.

    Mattjus P. Slotte J. P. (1996 ). Does cholesterol discriminate between sphingomyelin and phosphatidylcholine in mixed monolayers containing both phospholipids? Chem. Phys. Lipids 81, 69–80

    Not in our library10.1016/0009-3084(96)02535-2

34. 34.

    Mesmin B. Maxfield F. R. (2009 ). Intracellular sterol dynamics. Biochim. Biophys. Acta 1791, 636–645

    Not in our library10.1016/j.bbalip.2009.03.002

35. 35.

    Mondal M. Mesmin B. Mukherjee S. Maxfield F. R. (2009 ). Sterols are mainly in the cytoplasmic leaflet of the plasma membrane and the endocytic recycling compartment in CHO cells. Mol. Biol. Cell 20, 581–588

    Not in our library10.1091/mbc.e08-07-0785

36. 36.

    Mukherjee S. Chattopadhyay A. (1996 ). Membrane organization at low cholesterol concentrations: a study using 7-nitrobenz-2-oxa-1, 3-diazol-4-yl-labeled cholesterol. Biochemistry 35, 1311–1322

    Not in our library10.1021/bi951953q

37. 37.

    Nishio M. Umezawa Y. Hirota M. Takeuchi Y. (1995 ). The CH/π interaction: significance in molecular recognition. Tetrahedron 51, 8665–8701

    Not in our library

38. 38.

    Oddi S. Dainese E. Fezza F. Lanuti M. Barcaroli D. De Laurenzi V. (2011 ). Functional characterization of putative cholesterol binding sequence (CRAC) in human type-1 cannabinoid receptor. J. Neurochem. 116, 858–865

    Not in our library10.1111/j.1471-4159.2010.07041.x

39. 39.

    Paila Y. D. Chattopadhyay A. (2010 ). Membrane cholesterol in the function and organization of G-protein coupled receptors. Subcell. Biochem. 5, 439–466

    Not in our library10.1007/978-90-481-8622-8_16

40. 40.

    Paila Y. D. Tiwari S. Chattopadhyay A. (2009 ). Are specific nonannular cholesterol binding sites present in G-protein coupled receptors? Biochim. Biophys. Acta 1788, 295–302

    Not in our library10.1016/j.bbamem.2008.11.020

41. 41.

    Paila Y. D. Tiwari S. Sengupta D. Chattopadhyay A. (2011 ). Molecular modeling of the human serotonin (1A) receptor: role of membrane cholesterol in ligand binding of the receptor. Mol. Biosyst. 7, 224–234

    Not in our library10.1039/c0mb00148a

42. 42.

    Palmer M. (2004 ). Cholesterol and the activity of bacterial toxins. FEMS Microbiol. Lett. 238, 281–289

    Not in our library10.1016/j.femsle.2004.07.059

43. 43.
    Condensed complexes, rafts, and the chemical activity of cholesterol in membranes · 2000

    Not checked
44. 44.

    Rose I. A. Hanson K. R. Wilkinson K. D. Wimmer M. J. (1980 ). A suggestion for naming faces of ring compounds. Proc. Natl. Acad. Sci. U.S.A. 77, 2439–2441

    Not in our library10.1073/pnas.77.5.2439

45. 45.

    Rukmini R. Rawat S. S. Biswas S. C. Chattopadhyay A. (2001 ). Cholesterol organization in membranes at low concentrations: effects of curvature stress and membrane thickness. Biophys. J. 81, 2122–2134

    Not in our library10.1016/s0006-3495(01)75860-2

46. 46.

    Segrest J. P. De Loof H. Dohlman J. G. Brouillette C. G. Anantharamaiah G. M. (1990 ). Amphipathic helix motif: classes and properties. Proteins 8, 103–117

    Not in our library10.1002/prot.340080202

47. 47.

    Sengupta D. Chattopadhyay A. (2012 ). Identification of cholesterol binding sites in the serotonin1A receptor. J. Phys. Chem. B 116, 12991–12996

    Not in our library10.1021/jp309888u

48. 48.

    Simons K. Ikonen E. (1997 ). Functional rafts in cell membranes. Nature 387, 569–572

    Not in our library10.1038/42408

49. 49.

    Strandberg E. Killian J. A. (2003 ). Snorkeling of lysine side chains in transmembrane helices: how easy can it get? FEBS Lett. 544, 69–73

    Not in our library10.1016/s0014-5793(03)00475-7

50. 50.

    Thathiah A. De Strooper B. (2011 ). The role of G protein-coupled receptors in the pathology of Alzheimer's disease. Nat. Rev. Neurosci. 12, 73–87

    Not in our library10.1038/nrn2977

Cited by papers we hold 6

• Sonogenetic control of mammalian cells using exogenous Transient Receptor Potential A1 channels · 2022
  Corrected
• Antidepressant drugs act by directly binding to TRKB neurotrophin receptors · 2021
  No notice
• The Trypanosoma Brucei KIFC1 Kinesin Ensures the Fast Antibody Clearance Required for Parasite Infectivity · 2020
  Not checked
• Alzheimer’s Disease as a Membrane Disorder: Spatial Cross-Talk Among Beta-Amyloid Peptides, Nicotinic Acetylcholine Receptors and Lipid Rafts · 2019
  No notice
• There Is No Simple Model of the Plasma Membrane Organization · 2016
  No notice
• Cholesterol binding to ion channels · 2014
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.